Platinum–Ruthenium Cluster Complexes from the Reaction of Ru<Subscript>3</Subscript>(CO)<Subscript>12</Subscript> with Pt(PBu<Superscript>t</Superscript><Subscript>3</Subscript>)<Subscript>2</Subscript>

Three new platinum–ruthenium complexes: Pt₃Ru₃(PBu^t ₃)₃(CO)₁₂, 8, Pt₅Ru₃(PBu^t ₃)₃(CO)₁₂, 9 and PtRu₃(PBu^t ₃)₂(CO)₈(μ₃-PBu^t)(μ-H)₂, 10 were obtained from the reaction of Ru₃(CO)₁₂ with Pt(PBu^t ₃)₂. Compound 8 was obtained from this reaction when conducted at 25 °C. Compounds 9 and 10 were obtained when the reaction was conducted at 68 °C. The structure of 8 consists of a central triangular cluster of three ruthenium atoms with one Pt(PBu^t ₃) group bridging each of the three Ru–Ru bonds. The structure of 9 consists of a capped pentagonal bipyramidal cluster of eight metal atoms that is formed formally by the addition of two platinum atoms to 8. The structure of 10 contains a triangular cluster of three ruthenium atoms with a Pt(PBu^t ₃) group bridging one of the Ru–Ru bonds. A t-butyl phosphido ligand formed by degradation of a molecule of PBu^t ₃ bridges the three ruthenium atoms. This report is dedicated to the memory of Professor F. A. Cotton for his many pioneering contributions to inorganic and metal cluster chemistry.     

Graphite furnace atomic absorption spectrometric determination of iridium,rhodium and ruthenium in high-purity platinum after matrix extraction

Ir, Rh and Ru are separated from a large excess of platinum by extraction with isoamyl alcohol-isobutyl methyl ketone mixture. Graphite furnace atomic absorption spectrometry using the method of standard addition is then used to determine the metals with satisfactory precision and accuracy.     

The importance of cluster fragmentation in the catalytic hydrogenation of phenylacetylene by PtRu5 carbonyl cluster complexes

has been shown to be a catalyst precursor for the hydrogenation of PhC₂H to styrene and ethylbenzene. Three new organometallic products have been found in the catalyst solutions. These are , , and Ru₅(CO)₁₁(μ₄-CCHCPh)(μ₄-HC₂Ph)(μ₃-HC₂Ph) (6). Compounds 4-6 have been synthesized independently and structurally characterized and each one has been tested independently for its ability to produce hydrogenation of PhC₂H catalytically. Compound 4 contains an open square-pyramidal cluster of five ruthenium atoms with one platinum atom bridging an edge of the cluster. It is structurally related to 2 but contains one less CO ligand and two hydrido ligands formed by the addition of one equivalent of hydrogen to the metal cluster. It can be obtained directly from 2 by reaction with hydrogen in the presence of trimethylamine oxide. Compound 5 is a tricoordinated mononuclear platinum complex containing one ligand, one CO ligand and one μ₂-PhC₂H ligand. Compound 5 can be obtained directly from by reaction with PhC₂H under an atmosphere of CO. Compound 6 was obtained from the reaction of Ru₅(CO)₁₅(μ₅-C) with PhC₂H in the presence of UV-Vis irradiation. Compound 6 contains three equivalents of PhC₂H; one is present as triply bridging PhC₂H ligand; one is a quadruply bridging ligand; the third one has formed a bond to the carbido ligand in the center of the metal cluster to form a novel tetra-metallated allyl ligand. Compound 5 has the highest catalytic activity of all three compounds and is believed to be responsible for the vast majority of the catalytic hydrogenation produced from the solutions of 2. Compound 4 is transformed into 5 under the conditions of catalysis.     

Heteroleptic ruthenium bioflavonoid complexes: from synthesis to in vitro biological activity

Heteroleptic ruthenium(II) bioflavonoid complexes of quercetin, morin, chrysin, and 3-hydroxyflavone were prepared and their interaction with CT DNA and BSA along with antioxidant and in vitro anticancer and antimicrobial activities was investigated. The formulation and characterization of complexes were achieved through elemental and thermal analysis, mass spectrometry, ¹H NMR spectroscopy along with infrared, electronic absorption, and emission spectroscopy as well as square-wave voltammetry, and magnetic and conductivity measurements. Ruthenium(II) is octahedrally coordinated in cationic complex species to two bidentate diimine ligands (2,2′-bipyridine or 1,10-phenanthroline) and one bidentate monobasic flavonoid ligand through 3,4-site of quercetin, morin, and 3-hydroxyflavone or 4,5-site of chrysin. Complexes bind CT DNA by intercalation and binding constants comparable to ethidium bromide or 10 times higher. Binding constants of complexes to BSA were several times higher compared to ibuprofen and diazepam, and suggest that the complexes have a strong affinity to BSA. Antioxidant activity tests showed that the complexes are more potent in terms of radical inhibition compared to the parent flavonoids. Cytotoxic testing revealed that the Ru(II) complex of quercetin with 2,2′-bipyridine co-ligand has good selectivity to breast adenocarcinoma, while the complex of 3-hydroxyflavone with 2,2′-bipyridine co-ligand showed strong cytotoxicity toward all tested cell lines with IC₅₀ ～ 1 μM. All complexes showed moderate activity toward Acinetobacter baumannii, while the Ru(II) complex of 3-hydroxyflavone with 2,2′-bipyridine showed excellent activity toward MRSA and Candida albicans.     

Bimetallic cluster complexes: synthesis, structures and applications to catalysis

A brief history of the seminal discoveries in the field of bimetallic cluster complexes with their structures is presented. A review of some recent studies of palladium and platinum-ruthenium cluster complexes is concluded with a discussion of applications of these complexes in the area of homogeneous hydrogenation catalysis of alkynes.     

痕量Pt显著提升RuO2的酸性水分解性能(英文)

酸性电解水被认为是目前最具前景的制备高纯度氢气的途径之一.然而,该方法受到一些关键技术的限制,如电解水中的阳极反应——析氧反应(OER),目前仍效率偏低.Ru和Ir的氧化物是目前最具潜力的酸性OER催化剂,尤其是Ru O₂,不仅成本更低,而且OER活性更高.相较于IrO₂, RuO₂在酸性OER中更易溶解,导致其难以在活性与稳定性上保持良好的平衡.因此,设计同时具有高活性与高稳定性的Ru O₂基电催化剂十分迫切且具有挑战性.一般而言,催化剂性能与活性位点的局部电子环境密切相关,因为它能够有效调节反应中间体的吸附/解吸行为.在各种调控策略中,引入异原子已被证明是有效的.本文报道了通过痕量的Pt激活和稳定用于酸性水分解的Ru O₂催化剂的简便策略,其中Pt在促进OER中起到重要的调控作用,同时在析氢反应(HER)中充当着活性位点.通过简便的湿化学法并结合空气煅烧的后处理方式得到了含有5%Pt的RuO₂纳米组装片(5%Pt-RuONAs).球差校正透射电镜结果表...     

Heterotrimetallic and heterotetrametallic transition metal complexes

The synthesis of the ruthenium σ-acetylides (η⁵-C₅H₅)L₂Ru-CC-bipy (4a, L = PPh₃; 4b, L₂ = dppf; bipy = 2,2′-bipyridine-5-yl; dppf = 1,1′-bis(diphenylphosphino)ferrocene) is possible by the reaction of [(η⁵-C₅H₅)L₂RuCl] (1) with 5-ethynyl-2,2′-bipyridine (2a) in the presence of NH₄PF₆ followed by deprotonation with DBU. Heterobimetallic Fc-CC-NCN-Pt-CC-R (10a, R = bipy; 10b, R = C₅H₄N-4; Fc = (η⁵-C₅H₅)(η⁵-C₅H₄)Fe; NCN = [1,4-C₆H₂(CH₂NMe₂)₂-2,6]⁻) is accessible by the metathesis of Fc-CC-NCN-PtCl (9) with lithium acetylides LiCC-R (2a, R = bipy; 2b, R = C₅H₄N-4).The complexation behavior of 4a and 4b was investigated.Treatment of these molecules with [MnBr(CO)₅] (13) and {[Ti](μ-σ,π-CCSiMe₃)₂}MX (15a, MX = Cu(NCMe)PF₆; 15b, MX = Cu(NCMe)BF₄; 16, MX = AgOClO₃; [Ti] = (η⁵-C₅H₄SiMe₃)₂Ti), respectively, gave the heteromultimetallic transition metal complexes (η⁵- C₅H₅)L₂Ru-CC-bipy[Mn(CO)₃Br] (14a: L = PPh₃; 14b: L₂ = dppf) and [(η⁵-C₅H₅)L₂Ru-CC-bipy{[Ti](μ-σ,π-CCSiMe₃)₂}M]X (17a: L = PPh₃, M = Cu, X = BF₄; 17b: L₂ = dppf, M = Cu, X = PF₆; 18a: L = PPh₃, M = Ag, X = ClO₄; 18b: L₂ = dppf, M = Ag, X = ClO₄) in which the appropriate transition metals are bridged by carbon-rich connectivities.The solid-state structures of 4b, 10b, 12 and 17b are reported. The main structural feature of 10b is the square-planar-surrounded platinum(II) ion and its linear arrangement. In complex 12 the N-atom of the pendant pyridine unit coordinates to a [mer,trans-(NN′N)RuCl₂] (NN′N = 2,6-bis-[(dimethylamino)methyl]pyridine) complex fragment, resulting in a distorted octahedral environment at the Ru(II) centre. In 4b a 1,1′-bis(diphenylphosphino)ferrocene building block is coordinated to a cyclopentadienylruthenium-σ-acetylide fragment. Heterotetrametallic 17b contains a (η⁵-C₅H₅)(dppf)Ru-CC-bipy unit, the bipyridine entity of which is chelate-bonded to [{[Ti](μ-σ,π-CCSiMe₃)₂}Cu]⁺. Within this arrangement copper(I) is tetra-coordinated and hence, possesses a pseudo-tetrahedral coordination sphere.The electrochemical behavior of 4, 10b, 12, 17 and 18 is discussed. As typical for these molecules, reversible oxidation processes are found for the iron(II) and ruthenium(II) ions. The attachment of copper(I) or silver(I) building blocks at the bipyridine moiety as given in complexes 17 and 18 complicates the oxidation of ruthenium and consequently the reduction of the group-11 metals is made more difficult, indicating an interaction over the organic bridging units.The above described complexes add to the so far only less investigated class of compounds of heteromultimetallic carbon-rich transition metal compounds.     

Metal segregation in bimetallic clusters and its possible role in synergism and bifunctional catalysis

Aspects of the reactivity of segregated bimetallic compounds and their unusual catalytic properties are reviewed with an emphasis on the author's own studies of platinum—ruthenium mixed-metal cluster complexes and their ability to produce hydrogenation and hydrosilylation of alkynes, catalytically.     

Enhanced electrochemical activity for ethanol oxidation on the carbon-supported Pt3Te nanocatalysts by addition of Ru

Ternary Pt–Te–Ru catalysts with different atomic ratios were synthesized by reducing the precursor with formic acid. The physical and electrochemical characterization of the Pt₃TeRu_0.25/C catalyst was performed by transmission electron microscopy (TEM), X-ray diffraction, energy-dispersive X-ray spectroscopy equipped with TEM (TEM-EDX), X-ray photoelectron spectrometer, ethanol oxidation, and CO stripping. In TEM images, the Pt₃TeRu_0.25/C nanoparticles with an average particle size of around 2.9 nm were well dispersed on the carbon support. The Pt₃TeRu_0.25/C catalyst was superior to the Pt₃Te/C catalyst in respect of catalytic activity, durability, and CO tolerance. The positive effect of the Ru presence in the Pt₃TeRu_0.25/C catalyst was ascribed to the interactions of Ru or Ru oxides.     

Ruthenium-tin complexes from the reaction of HSnPh3 with Ru3(CO)10(NCMe)2 and their reactions with bis(tri-t-butylphosphine)platinum

The compounds Ru₃(CO)₉(SnPh₃)₂(NCMe)(μ-H)₂ (1), Ru₃(CO)₁₀(SnPh₃)₂(μ-H)₂ (2), Ru(CO)₄(SnPh₃)₂ (3) and Ru(CO)₄(SnPh₃)(H) (4) were obtained from the reaction of Ru₃(CO)₁₀(NCMe)₂ with HSnPh₃ in hexane solvent. Compounds 1, 3 and the new compound Ru₃(CO)₇(SnPh₃)₃(NCMe)₂(μ-H)₃ (5) were obtained from reaction of Ru₃(CO)₁₀(NCMe)₂ with HSnPh₃ in a CH₂Cl₂ and MeCN solvent mixture. Compound 2 and the new compound Ru₃(CO)₉(SnPh₃)₃(μ-H)₃ (6) were obtained from reactions of 1 and 5 with CO, respectively. Compounds 2 and 6 eliminated benzene when heated to yield Ru₃(CO)₁₀(μ-SnPh₂)₂ (7) and Ru₃(CO)₉(μ-SnPh₂)₃ (8) which contain bridging SnPh₂ ligands. Compound 7 was found to react with to yield the adduct, (9) in 59% yield by the addition of groups to two of the Ru-Sn bonds to the bridging SnPh₂ ligands. Fenske-Hall molecular orbital calculations were performed to provide an understanding of the metal-metal bonding in the clusters of 7 and 9. Compounds 1, 2, 5, 6, 7 and 9 were characterized structurally by single crystal X-ray diffraction analysis.     

Synthesis,characterization, and cytotoxic and antimicrobial activities of ruthenium(II) arene complexes with N,N-bidentate ligands

Three new complexes, [(η⁶-C₆H₆)RuCl(C₅H₄N-2-CH=N-Ar)]PF₆ (Ar = phenylmethylene (1), (4-methoxyphenyl)methylene (2), and phenylhydrazone (3)), were prepared by reacting [(η⁶-C₆H₆)Ru(μ-Cl)Cl]₂ with N,N′-bidentate ligands in a 1 : 2 ratio. Full characterization of the complexes was accomplished using ¹H and ¹³C NMR, elemental and thermal analyses, UV–vis and IR spectroscopy and single crystal X-ray structures. Single crystal structures confirmed a pseudo-octahedral three-legged, piano-stool geometry around Ru(II), with the ligand coordinated to the ruthenium(II) through two N atoms. The cytotoxicity of the mononuclear complexes was established against three human cancer cell lines and selectivity was also tested against non-cancerous human epithelial kidney (HEK 293) cells. The compounds were selective toward the tumor cells in contrast to the known anti-cancer drug 5-fluoro uracil which was not selective between the tumor cells and non-tumor cells. All the compounds showed moderate activity against MCF7 (human breast adenocarcinoma), but showed low antiproliferative activity against Caco-2 and HepG2. Also, antimicrobial activities of the complexes were tested against a panel of antimicrobial-susceptible and -resistant Gram-negative and Gram-positive bacteria. Of special interest is the anti-mycobacterial activity of all three synthesized complexes against Mycobacterium smegmatis, and bactericidal activity against resistant Enterococcus faecalis and methicillin-resistant Staphylococcus aureus ATCC 43300.     

An improved Brust’s procedure for preparing alkylamine stabilized Pt, Ru nanoparticles

An improved method to prepare alkylamine-stabilized Pt and Ru nanoparticles based on the original Brust’s procedure [J. Chem. Soc., Chem. Commun. (1994) 801] has been developed. The new method involves, firstly, mixing an aqueous solution of metal salts such as PtCl₆²⁻, PtCl₄²⁻ or Ru³⁺ with an ethanol solution of dodecylamine; extracting the metal ions into a toluene layer; and finally reducing the metal ions to their zero valent states using NaBH₄. Alkylamine-stabilized Pt nanoparticles prepared this way had a polyhedral or wormlike appearance, depending closely on the chemical nature of the metal precursor salts being used. On the contrary, dodecylamine-stabilized ruthenium nanoparticles were predominantly spherical. The particle formation and growth processes in the hydrocarbon layer could be influenced by the different ways dodecylamine was bound to H₂PtCl₆, K₂PtCl₄ or RuCl₃ at the precursor stage.     

Synthesis and spectral characterization of platinum(II) complexes containing eugenol,a natural allylphenol

For the first time, eugenol, a natural bioactive allylphenol, was introduced into coordination with platinum(II) by replacement of ethylene from Zeise’s salt with eugenol (Eug). The obtained complex, K[PtCl₃(Eug)] (1), was used as the key compound for preparation of the series of trans-[PtCl₂(Eug)(Amine)] (2–11), [PtCl(Eug)(8-O-quinoline)] (12) and [PtCl(Eug)(2-O₂C-quinoline)] (13). The synthesized complexes were characterized by elemental analyses, IR, ¹H NMR, ¹³C NMR, HSQS, HMBC, NOESY, and MS spectra. In 1–13 eugenol coordinates with Pt(II) at ethylenic double bond of the allyl group, the donor N of the amines is in trans-position in comparison with the double bond. A display of the trans-effect on the chemical shift of ¹H and ¹³C was remarked. Seven complexes were tested for cell in vitro cytotoxicity on human cancer cells. Complexes 3 and 12 exhibit high activities on Hep-G2 with IC₅₀ = 3.12 and 5.29 μM; 12 gives high activity against KB, Lu and MCF-7 with IC₅₀ = 0.43, 2.95 and 1.84 μM, respectively. Most of these IC₅₀ are lower than those of cisplatin.     

Synthesis,characterization and in vitro cytotoxicity of platinum(II) complexes of selenones [Pt(selenone)2Cl2]

Platinum(II) complexes with various selenones (L) having the general formula [PtL₂Cl₂] were prepared and characterized by elemental analysis and, IR and NMR (¹H, ¹³C, and ⁷⁷Se) spectroscopies. A decrease in the IR frequency of the >C=Se mode and an upfield shift in ¹³C NMR for the >C=Se resonance of selenones are consistent with their selenium coordination to platinum(II). The NMR data show that the complexes are stable in solution and do not undergo equilibration at 297 K. The geometrical structures of the complexes were predicted theoretically (with DFT method) using Gaussian09 program. DFT calculations predicted that the trans configurations were up to 1.7 kcal/mol more stable than the cis forms in gas phase, while in solution form the cis isomers were predicted to be more stable. The UV–vis spectra of the two complexes, 6 and 7 were also recorded at room temperature for 24 h and it was observed that the complexes were stable and did not undergo decomposition. The in vitro antitumor properties of the complexes as well as of cisplatin were evaluated on two human cancer cell lines, HeLa (cervical cancer cells) and MCF7 (breast cancer cells) using MTT assay. The results indicated that the prepared complexes exerted significant inhibition on the selected cancer cells.     

靶向抑制DNA拓扑异构酶的抗肿瘤药物研究

DNA拓扑异构酶是真核细胞和原核细胞中的一种基本酶,广泛存在于细胞核中,对DNA的转录、复制以及基因表达过程中的DNA拓扑结构的改变起着重要的作用。研究发现DNA拓扑异构酶在肿瘤组织中高度表达,许多抗肿瘤药物的作用机制与抑制拓扑异构酶有关,目前拓扑异构酶已成为筛选抗肿瘤药物的重要靶点。     

液相脉冲激光烧蚀法制备高熔点的纳米金属粒子

采用液相脉冲激光烧蚀法成功地制备了高熔点的金属Pt、Ru与Ag纳米粒子. 采用SEM、TEM、ED和紫外-可见吸收光谱表征了纳米粒子的特征. 纳米粒子的粒径基本在数个到数十个纳米的大小范围内. 发现含适量PVP(poly(vinylpyrrolidone))的水溶液有利于纳米粒子的制备, 而且还能够提高纳米粒子悬浮液的稳定性. 该制备方法较简单, 在制备高熔点的纳米金属粒子方面有着其它方法所不能比拟的优势.